Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ardelyx, Forte, Sorrento.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adamis, Assembly, Can-Fite, Connect, Inmune, Pfizer, Quantum, Quest, Takeda.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Heartflow.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astellas, Autolus, Bavarian Nordic, Code, Exevir, Immutep, Lumen, Merck, Pfizer, Revance, Ridgeback, Rigel, Tevogen, Xeris.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alivecor, Prevencio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AC Immune, Adial, Amarin, Axerovision, Bayer, Curevac, Genentech, Gennova, Gensight, GSK, HDT, J&J, Nocion, Pharmaxis, Poseida, Roche, Senhwa, SK Bioscience, Tauriga.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Affibody, Airway, Ascletis, Awakn Life Sciences, Bavarian Nordic, Bridgebio, Brii, Clarity, Edesa, Emergent Biosolutions, Eom, Everest Medicines, FSD, Hepagene, Hutchmed, Inmagene, Janssen Research & Development, Lianbio, Meiji Seika, Novavax, Noxopharm, Oncotelic, Pardes, Reistone, Senhwa, Turn.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Gala Therapeutics, Medalliance, Opko Health.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bayer, Bone, Daiichi, Janssen, Kinnov, Lysogene, Nrx, Pfizer, Regeneron, Sanofi, Uniqure.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott, Xact Robotics.